Objective: From the viewpoint of drug cost reduction, many generic drugs have appeared in the eye drops market.  Although the price of eye drops is defined on a per bottle (or per mL) basis, the difference in the total number of drops per bottle between the original drug and its generic drug may alter the drug cost reduction effect greatly.  Moreover, the difference in the total number of drops per bottle may also affect the number of pharmacy visits made by a patient in one year.
Methods: The total number of drops per bottle of an original drug and a generic drug was computed, and the influence of the number of drops on the drug cost reduction effect, including drug cost, was evaluated.
Results: Distinct differences in the volume per drop and the total number of drops per bottle were observed between the original drug and its generic drug, and those differences were found to clearly influence the drug cost reduction effect.  Moreover, in a survey of patients who shifted to generic eye drops, there were some patients who returned to the original eye drops because they could not apply the generic eye drops with ease or their eyes started to smart after using the generic eye drops.
Conclusion: This study revealed the need to take into consideration patient’s ease of use and the drug cost reduction effect, in the selection of eye drops.

Purpose: The learning situation of pharmacy students failing their final exam the previous year (referred to as US) was investigated, and a method of learning support for students with low scholastic abilities was examined.

Method: Questionnaires were completed by students who were unsuccessful in the previous year's final exam a total of three times from April to July 2014, and changes in their academic record were compared with the questionnaire results. Questionnaire contents were: (1)self-learning time, (2)learning support method, (3)weak subject area, (4) progress in the printed material we distributed.

Results: The students with a low academic performance hoped to study by themselves. They felt that physicochemistry and pharmacology were weak subject areas, because high-level understanding was necessary. We realized that the quality of learning was more important than the number of practice problems the students could complete, based on the tests we distributed. In addition, a decline in academic ability was seen in many students at the beginning of the following fiscal year.

Discussion: It is necessary to begin physicochemistry and pharmacology education support when students start their programs for those with a low scholastic ability. Support that incorporates unification-type learning for students unsuccessful in their final exams is also necessary. Furthermore, it is important to design specialized practice problems and individual guidance for students with a low academic performance.

In April 2014, a Letter of Rapid Safety Communication was issued, because 21 fatalities following administration of paliperidone palmitate (PP) were reported over a 5-month period since its launch in November, 2013. At the Department of Pharmacy of Hakodate Watanabe Hospital (our hospital), we established criteria for the use of long-acting antipsychotic injections (LAIs) when we began to prescribe LAIs at our hospital and shared information on the use of LAIs with pharmacists at community pharmacies by placing seals in medication notebooks. In March 2014, we conducted a questionnaire survey of pharmacists at 223 community pharmacies in Southern Hokkaido to compared the investigation items by the percentage of prescriptions filled in by the department of psychiatry among all the prescriptions dispensed by the pharmacies. The pharmacists who answered that injectable drug use information and seals for medication notebooks were necessary accounted for 75.8% and 74.2% of the responders, respectively. On the other hand, the percentages comprising the acquisition rates of information on injectable drug use and information on the injectable drugs used were low with 12.1% and 7.6% respectively. Also, a significant difference was seen in the recognition of LAI use in the comparison by the percentage of prescriptions filled in by the department of psychiatry among all of the prescriptions dispensed by the pharmacies (p＝0.001). Our results show that collaboration between hospital pharmacists and community pharmacists is necessary to ensure the safe use of LAI.